In January 2015, the Supreme Court of the United States decided on the Copaxone patent in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc..==Subsidiaries==*Africa**Assia Pharmaceuticals Ltd.**Teva Pharmaceuticals (Pty) Ltd.*Asia**Oncotest**Ratio Pharma**TAPI Teva API Israel**Teva API India Ltd.**Teva Israel**Teva Japan**Teva Singapore**Teva SLE*North America**Barr Pharmaceuticals**Plantex USA**Teva Animal Health**Teva Biopharmaceuticals USA**Teva Canada**Teva Mexico**Teva Neuroscience**Teva Neuroscience Canada**Teva Parenteral Medicines**Teva Pharmaceuticals Curaçao N.V.**Teva Pharmaceuticals USA**Teva Specialty Pharmaceuticals*South America**Teva Perú (Corporación Medco and Infarmasa)**Ivax Argentina**Laboratorio Chile**Teva Brazil*Europe**Med Ilaç A.Ş.
** Oncotest** TAPI Teva API Israel** Teva API India Ltd.** Teva Japan** Teva Singapore** Ratio Pharma** Barr Pharmaceuticals** Plantex USA** Teva Animal Health** Teva Biopharmaceuticals USA** Teva Canada** Teva Mexico** Teva Neuroscience** Teva Neuroscience Canada** Teva Parenteral Medicines** Teva Pharmaceuticals Curaçao N.V.** Teva Pharmaceuticals USA** Teva Specialty Pharmaceuticals** Teva Perú (Corporación Medco and Infarmasa)** Ivax Argentina** Laboratorio Chile** Teva Brazil** Med Ilaç A.Ş.